Skip to search formSkip to main contentSkip to account menu

neo-gambogic acid

Known as: 2-Butenoic acid, 4-(3a,4,5,7,10,11-hexahydro-8,9-dihydroxy-3,3,11-trimethyl-13-(3-methyl-2-butenyl)-11-(4-methyl-3-pentenyl)-7,15-dioxo-1,5-methano-1H,3H,9H-furo(3,4-g)pyrano(3,2-b)xanthen-1-yl)-2-methyl-, neogambogic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Objective;To study the liver targeting of neogambogic acid nanocapsules in mice.Methods;The concentration of NGA in the heart… 
2012
2012
Objective To investigate the effects of neogambogic acid on proliferation and apoptosis of human breast cancer cell line MCF-7… 
2012
2012
Objective: To establish a HPLC method for determinating the content of puerarin in Dange capsules.Methods: The determination of… 
2011
2011
Objective:T0 establish a HPLC method for determinating the content of neogambogic acid in Furong Gel.Methods: The determination… 
2011
2011
Aim To detect the stability of solid lipid nanoparticle in rat plasma.Methods Through detecting and contrasting the leakage rate… 
2008
2008
Objective To investigate the antitumor effects of neogambogic acid both in vivo and in vitro.Methods Cancer cell lines were… 
2006
2006
The invention relates to an oral preparation of neogambogic acid for treating tumor, which comprises (by weight ratio…